Tagged with Rare Diseases

Giannis Sotiriou – CEO, Institute of Pharmaceutical Research and Technology (IFET), Greece
Germany Pharma News: Bayer CEO on Thin Ice; Merck Manufacturing Expansion; STADA Launches First Rare Kidney Disease Drug
Dirk Van Niekerk – Managing Director South America, Boehringer Ingelheim
Eriona Gjinukaj, Chief Operating Officer – Dompé
Rare Diseases: Reverse Engineering for Drug Development
Norberto Villarrasa Justicia – Cluster Head Spain, Italy & Portugal, Kyowa Kirin
Orphan Drugs: EURORDIS & EFPIA Push for Broader Access
Orphan Drugs & Rare Diseases: Brazil
Pierluigi Antonelli – CEO, Angelini Pharma
Claudia Coscia – Southern Cluster Lead Nephrology & Country Manager Italy, Kyowa Kirin
Pablo De Mora – VP and General Manager, Sobi Spain & Portugal
Maria Jose Sanchez Losada – President, AELMHU, Spain
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here